Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Rojek AE"'
Autor:
Orellana-Noia, VM, Reed, DR, McCook, AA, Sen, JM, Barlow, CM, Malecek, M-K, Watkins, M, Kahl, BS, Spinner, MA, Advani, R, Voorhees, TJ, Snow, A, Grover, NS, Ayers, A, Romancik, JT, Liu, Y, Huntington, SF, Chavez, JC, Saeed, H, Lazaryan, A, Raghunathan, V, Spurgeon, SE, Ollila, TA, Del Prete, C, Olszewski, AJ, Ayers, EC, Landsburg, DJ, Echalier, B, Lee, J, Kamdar, M, Caimi, PF, Fu, T, Liu, J, David, KA, Alharthy, H, Law, J, Karmali, R, Shah, H, Stephens, DM, Major, A, Rojek, AE, Smith, SM, Yellala, A, Kallam, A, Nakhoda, S, Khan, N, Sohail, MA, Hill, BT, Barrett-Campbell, O, Lansigan, F, Switchenko, J, Cohen, JB, Portell, CA
Publikováno v:
Blood; 20210101, Issue: Preprints
Autor:
Alsouqi A; Division of Hematology and Oncology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA., Ahmed G; BMT & Cellular Therapy Program, Medical College of Wisconsin, Milwaukee, Wisconsin, USA., Wang J; Division of Biostatistics, Medical College of Wisconsin, Milwaukee, Wisconsin, USA., Cassanello G; Adult Bone Marrow Transplant Service, Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Department of Oncology and Onco-hematology, University of Milan, Milan, Italy., Szabo A; Division of Biostatistics, Medical College of Wisconsin, Milwaukee, Wisconsin, USA., Rojek AE; David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, Illinois, USA., Riedell PA; David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, Illinois, USA., Awan F; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas, USA., Samples L; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Shadman M; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Hu M; Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, Minnesota, USA., Bachanova V; Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, Minnesota, USA., Wesson W; Division of Hematologic Malignancies and Cellular Therapy, University of Kansas Cancer Center, Kansas City, Kansas, USA., Ahmed N; Division of Hematologic Malignancies and Cellular Therapy, University of Kansas Cancer Center, Kansas City, Kansas, USA., Iqbal M; Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, Florida, USA., Kharfan-Dabaja MA; Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, Florida, USA., Scordo M; Adult Bone Marrow Transplant Service, Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Johnson PC; Hematopoietic Cell Transplant and Cellular Therapy Program, Massachusetts General Hospital - Harvard Medical School, Boston, Massachusetts, USA., Chen YB; Hematopoietic Cell Transplant and Cellular Therapy Program, Massachusetts General Hospital - Harvard Medical School, Boston, Massachusetts, USA., Ito S; Division of Hematology and Oncology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA., Hamadani M; BMT & Cellular Therapy Program, Medical College of Wisconsin, Milwaukee, Wisconsin, USA., Frigault M; Hematopoietic Cell Transplant and Cellular Therapy Program, Massachusetts General Hospital - Harvard Medical School, Boston, Massachusetts, USA.
Publikováno v:
American journal of hematology [Am J Hematol] 2024 Aug; Vol. 99 (8), pp. 1624-1627. Date of Electronic Publication: 2024 May 20.
Real-world outcomes of intensive induction approaches in core binding factor acute myeloid leukemia.
Autor:
Rojek AE; Department of Medicine Section of Hematology/Oncology University of Chicago Chicago Illinois USA., McCormick BJ; Division of Hematology-Oncology Blood and Marrow Transplantation Program Mayo Clinic Jacksonville Florida USA., Cwykiel J; Department of Medicine Division of Hematology and Oncology Robert H. Lurie Comprehensive Cancer Center Northwestern University Feinberg School of Medicine Chicago Illinois USA., Odetola O; Department of Medicine Division of Hematology and Oncology Robert H. Lurie Comprehensive Cancer Center Northwestern University Feinberg School of Medicine Chicago Illinois USA., Abaza Y; Department of Medicine Division of Hematology and Oncology Robert H. Lurie Comprehensive Cancer Center Northwestern University Feinberg School of Medicine Chicago Illinois USA., Nai N; Department of Internal Medicine University of New Mexico School of Medicine Albuquerque New Mexico USA., Foucar CE; Department of Internal Medicine Division of Hematology and Oncology University of New Mexico School of Medicine Albuquerque New Mexico USA., Achar RK; Department of Internal Medicine Section of Hematology Yale School of Medicine Yale University New Haven Connecticut USA., Shallis RM; Department of Internal Medicine Section of Hematology Yale School of Medicine Yale University New Haven Connecticut USA., Bradshaw D; Georgia Cancer Center Augusta University Augusta Georgia USA., Standridge M; Department of Internal Medicine Augusta University Medical College of Georgia Augusta Georgia USA., Kota V; Georgia Cancer Center Augusta University Augusta Georgia USA., Murthy GSG; Division of Hematology/Oncology Medical College of Wisconsin Milwaukee Wisconsin USA., Badar T; Division of Hematology-Oncology Blood and Marrow Transplantation Program Mayo Clinic Jacksonville Florida USA., Patel AA; Department of Medicine Section of Hematology/Oncology University of Chicago Chicago Illinois USA.
Publikováno v:
EJHaem [EJHaem] 2024 Jul 24; Vol. 5 (4), pp. 728-737. Date of Electronic Publication: 2024 Jul 24 (Print Publication: 2024).
CAR T-cell therapy in mantle cell lymphoma with secondary CNS involvement: a multicenter experience.
Autor:
Ahmed G; Division of Hematology-Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI., Alsouqi A; Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA., Szabo A; Division of Hematology-Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI., Samples L; Division of Hematology-Oncology, Department of Medicine, Fred Hutchinson Cancer Center, Seattle, WA., Shadman M; Division of Hematology-Oncology, Department of Medicine, Fred Hutchinson Cancer Center, Seattle, WA., Awan FT; Division of Hematology-Oncology, Department of Medicine, University of Texas Southwestern Medical Center, Dallas, TX., Rojek AE; David and Etta Jonas Center for Cellular Therapy, The University of Chicago, Chicago, IL., Riedell PA; David and Etta Jonas Center for Cellular Therapy, The University of Chicago, Chicago, IL., Iqbal M; Division of Hematology-Oncology, Department of Medicine, Mayo Clinic Florida, Jacksonville, FL., Fenske TS; Division of Hematology-Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI., Kharfan-Dabaja MA; Division of Hematology-Oncology, Department of Medicine, Mayo Clinic Florida, Jacksonville, FL., Ito S; Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA., Hamadani M; Division of Hematology-Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI.
Publikováno v:
Blood advances [Blood Adv] 2024 Jul 09; Vol. 8 (13), pp. 3528-3531.
Autor:
Kaur A; Department of Pathology, Sections of Hematopathology and Genomic Pathology, University of Chicago Medicine, Chicago, IL, USA., Rojek AE; Hematology/Oncology Department of Medicine, University of Chicago Medicine, Chicago, IL, USA., Symes E; Department of Pathology, Sections of Hematopathology and Genomic Pathology, University of Chicago Medicine, Chicago, IL, USA., Nawas MT; Hematology/Oncology Department of Medicine, University of Chicago Medicine, Chicago, IL, USA., Patel AA; Hematology/Oncology Department of Medicine, University of Chicago Medicine, Chicago, IL, USA., Patel JL; Departments of Pathology and Hematology/Oncology, University of Utah/ARUP, Salt Lake City, UT, USA., Sojitra P; Department of Pathology, Rutgers Robert Wood Johnson Medical School New Brunswick NJ, New Brunswick, NJ, USA., Aqil B; Department of Pathology, Northwestern Memorial Hospital, Chicago, IL, USA., Sukhanova M; Department of Pathology, Northwestern Memorial Hospital, Chicago, IL, USA., McNerney ME; Department of Pathology, Sections of Hematopathology and Genomic Pathology, University of Chicago Medicine, Chicago, IL, USA., Wu LP; Department of Pathology, Sections of Hematopathology and Genomic Pathology, University of Chicago Medicine, Chicago, IL, USA., Akmatbekov A; Department of Pathology, Sections of Hematopathology and Genomic Pathology, University of Chicago Medicine, Chicago, IL, USA., Segal J; Department of Pathology, Sections of Hematopathology and Genomic Pathology, University of Chicago Medicine, Chicago, IL, USA., Tjota MY; Department of Pathology, Sections of Hematopathology and Genomic Pathology, University of Chicago Medicine, Chicago, IL, USA., Gurbuxani S; Department of Pathology, Sections of Hematopathology and Genomic Pathology, University of Chicago Medicine, Chicago, IL, USA., Cheng JX; Department of Pathology, Sections of Hematopathology and Genomic Pathology, University of Chicago Medicine, Chicago, IL, USA., Yeon SY; Department of Pathology, University of Illinois, Chicago, IL, USA., Ravisankar HV; Department of Pathology, Sections of Hematopathology and Genomic Pathology, University of Chicago Medicine, Chicago, IL, USA., Fitzpatrick C; Department of Pathology, Sections of Hematopathology and Genomic Pathology, University of Chicago Medicine, Chicago, IL, USA., Lager A; Hematology/Oncology Department of Medicine, University of Chicago Medicine, Chicago, IL, USA., Drazer MW; Hematology/Oncology Department of Medicine, University of Chicago Medicine, Chicago, IL, USA., Saygin C; Hematology/Oncology Department of Medicine, University of Chicago Medicine, Chicago, IL, USA., Wanjari P; Department of Pathology, Sections of Hematopathology and Genomic Pathology, University of Chicago Medicine, Chicago, IL, USA., Katsonis P; Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA., Lichtarge O; Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA., Churpek JE; Division of Hematology, Department of Medicine, University of Wisconsin, Madison, WI, USA., Ghosh SB; Department of Pathology, Henry Ford Health Systems, Detroit, MI, USA., Patel AB; Departments of Pathology and Hematology/Oncology, University of Utah/ARUP, Salt Lake City, UT, USA., Menon MP; Departments of Pathology and Hematology/Oncology, University of Utah/ARUP, Salt Lake City, UT, USA., Arber DA; Department of Pathology, Sections of Hematopathology and Genomic Pathology, University of Chicago Medicine, Chicago, IL, USA., Wang P; Department of Pathology, Sections of Hematopathology and Genomic Pathology, University of Chicago Medicine, Chicago, IL, USA., Venkataraman G; Department of Pathology, Sections of Hematopathology and Genomic Pathology, University of Chicago Medicine, Chicago, IL, USA. girish.venkataraman@uchospitals.edu.
Publikováno v:
Blood cancer journal [Blood Cancer J] 2024 Jun 18; Vol. 14 (1), pp. 99. Date of Electronic Publication: 2024 Jun 18.
Autor:
Rojek AE; Department of Medicine, Section of Hematology-Oncology, University of Chicago, Chicago, IL., Kline JP; Department of Medicine, Section of Hematology-Oncology, University of Chicago, Chicago, IL; David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL., Feinberg N; Department of Radiology, Section of Nuclear Medicine, University of Chicago, Chicago, IL., Appelbaum DE; Department of Radiology, Section of Nuclear Medicine, University of Chicago, Chicago, IL., Pu Y; Department of Radiology, Section of Nuclear Medicine, University of Chicago, Chicago, IL., Derman BA; Department of Medicine, Section of Hematology-Oncology, University of Chicago, Chicago, IL; David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL., Jakubowiak A; Department of Medicine, Section of Hematology-Oncology, University of Chicago, Chicago, IL; David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL., Kosuri S; Department of Medicine, Section of Hematology-Oncology, University of Chicago, Chicago, IL; David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL., Liu H; Department of Medicine, Section of Hematology-Oncology, University of Chicago, Chicago, IL; David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL., Nawas MT; Department of Medicine, Section of Hematology-Oncology, University of Chicago, Chicago, IL; David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL., Smith SM; Department of Medicine, Section of Hematology-Oncology, University of Chicago, Chicago, IL., Bishop MR; Department of Medicine, Section of Hematology-Oncology, University of Chicago, Chicago, IL; David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL., Riedell PA; Department of Medicine, Section of Hematology-Oncology, University of Chicago, Chicago, IL; David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL. Electronic address: Peter.Riedell@bsd.uchicago.edu.
Publikováno v:
Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2024 Feb; Vol. 24 (2), pp. 83-93. Date of Electronic Publication: 2023 Sep 16.
Autor:
Rojek AE; Department of Medicine, University of Chicago, Chicago, Illinois., Schiller PT; Department of Medicine, University of Chicago, Chicago, Illinois.
Publikováno v:
JAMA health forum [JAMA Health Forum] 2022 Sep 02; Vol. 3 (9), pp. e223023. Date of Electronic Publication: 2022 Sep 02.
Autor:
Santhosh L; Department of Medicine, University of California, San Francisco., Rojek AE; Department of Medicine, University of Chicago, Chicago, Illinois., Yim JWL; Health Informatics, UCSF Health, University of California, San Francisco., Lisker S; Department of Medicine, University of California, San Francisco.; UCSF Center for Vulnerable Populations, San Francisco, San Francisco., Wang K; UCSF Center for Vulnerable Populations, San Francisco, San Francisco., Dy M; Department of Medicine, University of California, San Francisco.; UCSF Center for Vulnerable Populations, San Francisco, San Francisco., Sarkar U; Department of Medicine, University of California, San Francisco.; UCSF Center for Vulnerable Populations, San Francisco, San Francisco.
Publikováno v:
JAMA network open [JAMA Netw Open] 2022 Aug 01; Vol. 5 (8), pp. e2227948. Date of Electronic Publication: 2022 Aug 01.
Autor:
Rojek AE; Resident physician, Department of Internal Medicine, University of Chicago Medical Center, Chicago, Illinois; email: alexandra.rojek@uchospitals.edu ; Twitter: @AlexandraRojek ., Schiller PT; Resident physician, Department of Internal Medicine, University of Chicago Medical Center, Chicago, Illinois.
Publikováno v:
Academic medicine : journal of the Association of American Medical Colleges [Acad Med] 2022 Jul 01; Vol. 97 (7), pp. 946-947. Date of Electronic Publication: 2022 Jun 23.
Autor:
Rojek AE; Department of Medicine, University of Chicago, Chicago, IL, USA., Smith SM; Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL, USA. smsmith@medicine.bsd.uchicago.edu.
Publikováno v:
Blood cancer journal [Blood Cancer J] 2022 Feb 24; Vol. 12 (2), pp. 33. Date of Electronic Publication: 2022 Feb 24.